Recalls

Voluntary and Limited Recall of Harry London Chocolate Pecan Caramel Stars Due to an Undeclared Allergen

North Canton, Ohio–(ENEWSPF)–January 6, 2010.

Proud member of LION Publishers

Harry London today announced it is voluntarily recalling 3310 individual units of the 4.62 ounce Harry London Chocolate Pecan Caramel Stars because they have not been labeled to include Wheat, FD&C colors Yellow #5, Red # 40 and Blue #1 as an ingredient. All Harry London Chocolate Pecan Caramel Stars sold after 28 December 2009 have the correct labeling.

No illnesses or injuries have been reported to date.  Harry London discovered the error during a routine quality control process check.  The product is produced with a Pecan flavored wheat germ nut that is made with wheat and FD&C colorings, which were not stated in the ingredient disclosure label.

Although in all cases the package has an allergen statement indicating the product was manufactured on equipment shared with peanuts, tree nuts, soybeans, milk, eggs, and wheat, Harry London is undertaking this voluntary recall out of an abundance of caution. This voluntary recall does not affect any other products from Harry London.

The product being recalled is the Harry London Chocolate Pecan Caramel Stars Lot code number 9238-1

A photograph of the product is below and also available on our website, www.harrylondon.com, to help with identification.

Working in cooperation with FDA, Harry London will also issue an alert through The Food Allergy and Anaphylaxis Network (www.foodallergy.org).  Anyone who has the identified product with this Lot code in their possession should be aware of this Alert and take appropriate measures.  Consumers affected by this Alert should avoid consumption and destroy the product.  Consumers with questions may contact Harry London at (330) 494-0833 ext. 193, Monday through Friday, 8:30 A.M. – 5:00 P.M. EST.

Harry London apologizes for any inconvenience this may cause our valued customers; product quality and consumer safety have always been our top priority.

 

Source: fda.gov

Most read stories this week

Take a Survey

ARCHIVES